CD8A and neoplasm: Therefore, we propose that the most effective immunotherapy for TLP would involve a sequence starting with conventional therapy to reduce tumor burden and enhance immunogenicity, followed by the establishment of an appropriate CD8 T cell landscape within the tumor using rhIL-7-hyFc treatment, and finally, the application of ICB to achieve superior effector functions of CD8 T cells.